Say it Ain’t So…New Hep C Drug to Surpass $84,000
Share
Follow Us
The Editors at Hepatitis Central
September 15, 2014
The new drug from Gilead could reach upwards of $95,000 – $100,000; but learn why Gilead expects savings for some patients in its pricing scheme.
Gilead to raise price for new hepatitis C drug above $84,000
By Deena Beasley
September 12, 2014
(Reuters) – The next generation version of Gilead Sciences Inc’s $84,000 hepatitis C drug, already under fire for its record-breaking costs, is going to be even more expensive.
Gregg Alton, Gilead’s executive vice president of corporate and medical affairs, declined to give an exact price for the new medicine, the first all-oral treatment for the virus which is expected to launch next month.
Continue reading this entire article:
http://www.reuters.com/article/2014/09/12/us-gilead-sovaldi-idUSKBN0H72KR20140912
